These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24843084)

  • 41. Foam sclerotherapy--a possible option in therapy of varicose veins.
    Kendler M; Wetzig T; Simon JC
    J Dtsch Dermatol Ges; 2007 Aug; 5(8):648-54. PubMed ID: 17659037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exacerbation of alopecia areata: A possible complication of sodium tetradecyl sulphate foam sclerotherapy treatment for varicose veins.
    Whiteley MS; Smith VC
    SAGE Open Med Case Rep; 2017; 5():2050313X17712643. PubMed ID: 28616235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy.
    Schuller-Petrović S; Pavlović MD; Neuhold N; Brunner F; Wölkart G
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):983-6. PubMed ID: 21740464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Principles and technique of foam sclerotherapy and its specific use in the treatment of venous leg ulcers.
    Simka M
    Int J Low Extrem Wounds; 2011 Sep; 10(3):138-45. PubMed ID: 21856975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in venous function after foam sclerotherapy of varicose veins.
    Brunken A; Rabe E; Pannier F
    Phlebology; 2009 Aug; 24(4):145-50. PubMed ID: 19620696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins.
    Myers KA; Jolley D
    Eur J Vasc Endovasc Surg; 2008 Nov; 36(5):602-5. PubMed ID: 18718772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Echo-guided compression sclerotherapy using foam: an improvement in the treatment of varicose veins].
    Kockaert MA; de Roos KP; Neumann HA
    Ned Tijdschr Geneeskd; 2006 Aug; 150(32):1758-63. PubMed ID: 16948234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Injection sclerotherapy for varicosities of the lower limb: 25 years of experience with 115000 injections].
    Bihari I
    Orv Hetil; 2007 Jan; 148(2):51-8. PubMed ID: 17344119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is the treatment of the small saphenous veins with foam sclerotherapy at risk of deep vein thrombosis?
    Gillet JL; Lausecker M; Sica M; Guedes JM; Allaert FA
    Phlebology; 2014 Oct; 29(9):600-7. PubMed ID: 23864534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of endovenous laser ablation on restless legs syndrome.
    Hayes CA; Kingsley JR; Hamby KR; Carlow J
    Phlebology; 2008; 23(3):112-7. PubMed ID: 18467618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in health-related quality of life after ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins.
    Darvall KA; Sam RC; Bate GR; Silverman SH; Adam DJ; Bradbury AW
    J Vasc Surg; 2010 Apr; 51(4):913-20. PubMed ID: 20347688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases.
    Krokidis M; Venetucci P; Hatzidakis A; Iaccarino V
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S228-31. PubMed ID: 20559638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Review of published information on foam sclerotherapy.
    Stücker M; Kobus S; Altmeyer P; Reich-Schupke S
    Dermatol Surg; 2010 Jun; 36 Suppl 2():983-92. PubMed ID: 20590705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
    VAN Deurzen B; Ceulen RP; Tellings SS; VAN DER Geld C; Nijsten T
    Dermatol Surg; 2011 Oct; 37(10):1448-55. PubMed ID: 21790848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Foam sclerotherapy for the treatment of superficial venous insufficiency.
    Gibson KD; Ferris BL; Pepper D
    Surg Clin North Am; 2007 Oct; 87(5):1285-95, xii-xiii. PubMed ID: 17936487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic venous disease treated by ultrasound guided foam sclerotherapy.
    Smith PC
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):577-83. PubMed ID: 16782367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An investigation on the influence of glycerin on sclerosant foam stability.
    Peterson JD; Goldman MP
    Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study.
    Peterson JD; Goldman MP
    Phlebology; 2012 Mar; 27(2):73-6. PubMed ID: 21926097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Basic physiochemical and rheological properties of detergent sclerosants.
    Wong K; Chen T; Connor DE; Behnia M; Parsi K
    Phlebology; 2015 Jun; 30(5):339-49. PubMed ID: 24671525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of sclerotherapy in abnormal varicose hand veins.
    Duffy DM; Garcia C; Clark RE
    Plast Reconstr Surg; 1999 Oct; 104(5):1474-9; discussion 1480-1. PubMed ID: 10513934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.